[{"data":1,"prerenderedAt":226},["ShallowReactive",2],{"drug-meningococcal-vaccine":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":23,"regimens":37,"contraindications":91,"warnings":101,"renal":102,"monitoring":103,"interactions":104,"review":105,"examples":108,"atc":123,"iran":125,"usApproval":173,"links":179,"populations":193},"meningococcal-vaccine",1,{"fa":7,"en":8},"واکسن مننگوکوک ACWY (کونژوگه)","Meningococcal ACWY conjugate vaccine","anti-infectives",{"fa":11,"en":12},"واکسن کونژوگه","Conjugate vaccine",[14],{"name":15,"market":16},"Menveo","US",[18,19,20,21,22],"menveo","menactra","mcv4","واکسن مننژیت","مننگوکوک",[24],{"id":25,"form":26,"route":27,"label":28,"concentration":29,"markets":32,"refs":33},"vial-05","injection","im","0.5 mL dose (two-vial for 2 months–55 y; one-vial for 10–55 y)",{"amount":30,"unit":31,"perVolumeMl":30},0.5,"mL",[16],[34],{"source":35,"section":36},"fda-menveo","3",[38,56,69],{"id":39,"disease":40,"label":41,"population":44,"type":50,"unit":31,"dose":51,"refs":52,"durationDays":55},"infant","immunization",{"fa":42,"en":43},"شیرخوار از ۲ ماهگی — ۴ دوز در ۲، ۴، ۶ و ۱۲ ماهگی","Infants from 2 months — 4 doses at 2, 4, 6 and 12 months",{"minAge":45,"maxAge":48},{"value":46,"unit":47},2,"month",{"value":49,"unit":47},7,"fixed",{"perDose":30,"dosesPerDay":5},[53],{"source":35,"section":54},"2.4, Table 1",{"min":5,"max":5},{"id":57,"disease":40,"label":58,"population":61,"type":50,"unit":31,"dose":65,"refs":66,"durationDays":68},"toddler",{"fa":59,"en":60},"۷ تا ۲۳ ماه — ۲ دوز (دوز دوم در سال دوم و دست‌کم ۳ ماه پس از اول)","7–23 months — 2 doses (second in the 2nd year, ≥3 months after the first)",{"minAge":62,"maxAge":63},{"value":49,"unit":47},{"value":46,"unit":64},"year",{"perDose":30,"dosesPerDay":5},[67],{"source":35,"section":54},{"min":5,"max":5},{"id":70,"disease":40,"label":71,"population":74,"type":50,"unit":31,"dose":78,"refs":79,"durationDays":81,"notes":82},"std",{"fa":72,"en":73},"۲ تا ۵۵ سال — یک دوز ۰٫۵ mL عضلانی","2–55 y — single 0.5 mL IM dose",{"minAge":75,"maxAge":76},{"value":46,"unit":64},{"value":77,"unit":64},56,{"perDose":30,"dosesPerDay":5},[80],{"source":35,"section":54},{"min":5,"max":5},[83],{"text":84,"refs":87},{"fa":85,"en":86},"کودک ۲ تا ۵ سال در خطر مداوم: دوز دوم ۲ ماه بعد. یادآور ۱۵ تا ۵۵ سال در خطر مداوم: یک دوز. زیر ۱۰ سال فقط فرآورده دوویالی.","Children 2–5 y at continued risk: a second dose 2 months later. Booster at 15–55 y if at continued risk: one dose. Under 10 y only the two-vial presentation.",[88,89],{"source":35,"section":54},{"source":35,"section":90},"8.4",[92],{"id":93,"severity":94,"text":95,"refs":98},"allergy","block",{"fa":96,"en":97},"واکنش آلرژیک شدید (آنافیلاکسی) به اجزای واکسن یا دوز قبلی یا هر واکسن حاوی توکسوئید دیفتری.","Severe allergic reaction (anaphylaxis) to a vaccine component or a previous dose or any diphtheria toxoid-containing vaccine.",[99],{"source":35,"section":100},"4",[],[],[],[],{"status":106,"reviewer":107,"date":107},"unverified",null,[109,113,118],{"regimen":39,"formulation":25,"input":110,"expect":112},{"ageMonths":46,"weightKg":111},5,{"perDose":30,"mlPerDose":30},{"regimen":57,"formulation":25,"input":114,"expect":117},{"ageMonths":115,"weightKg":116},10,9,{"perDose":30,"mlPerDose":30},{"regimen":70,"formulation":25,"input":119,"expect":122},{"ageYears":120,"weightKg":121},17,60,{"perDose":30,"mlPerDose":30},[124],"J07AH08",{"status":126,"forms":127,"refs":168},"registered",[128,132,136,140,144,148,152,156,160,164],{"code":129,"en":130,"fa":131},"04682","MENINGOCOCCAL ACWY 10DOSE VIAL","ویال مننگوکوکی آکوی ۱۰ دوز",{"code":133,"en":134,"fa":135},"21258","MENINGOCOCCAL ACWY 1DOSE VIAL","ویال مننگوکوکی آکوی ۱ دوز",{"code":137,"en":138,"fa":139},"17878","MENINGOCOCCAL VAC A+C 1 DOSE VIAL","ویال مننگوکوکی VAC A + C ۱ دوز",{"code":141,"en":142,"fa":143},"17876","MENINGOCOCCAL VAC A+C 10 DOSE VIAL","ویال مننگوکوکی VAC A + C ۱۰ دوز",{"code":145,"en":146,"fa":147},"01583","MENINGOCOCCAL VAC A+C 50 DOSES","مننگوکوکی VAC A + C ۵۰ دوز",{"code":149,"en":150,"fa":151},"19637","MENINGOCOCCAL VACCINE POLYVALENT 1DOSE SYRINGE","سرنگ واکسن مننگوکوکی چندظرفیتی ۱ دوز",{"code":153,"en":154,"fa":155},"19636","MENINGOCOCCAL VACCINE POLYVALENT 1DOSE VIAL","ویال واکسن مننگوکوکی چندظرفیتی ۱ دوز",{"code":157,"en":158,"fa":159},"02721","VACCINE-MENIGOCOCCAL A+C 10 DOSES AMP","آمپول واکسن–منیگوکوککال A + C ۱۰ دوز",{"code":161,"en":162,"fa":163},"52305","MENINGOCOCCAL VACCINE INJECTION PARENTERAL  10 {dose}","فرآورده تزریقی واکسن مننگوکوکی ۱۰ { دوز }",{"code":165,"en":166,"fa":167},"52293","MENINGOCOCCAL VACCINE INJECTION PARENTERAL  1 {dose}","فرآورده تزریقی واکسن مننگوکوکی ۱ { دوز }",[169],{"source":170,"section":171,"url":172},"darooyab-generic","G-3488\u002FMeningococcal-Vaccines","https:\u002F\u002Fwww.darooyab.ir\u002FG-3488\u002FMeningococcal-Vaccines",{"kind":174,"refs":175,"id":178},"BLA",[176],{"source":35,"section":177},"SPL approval \u002F marketing category","BLA125300",[180,183,187,190],{"kind":181,"url":182,"label":178},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=125300",{"kind":184,"url":185,"label":186},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=2dc730d5-55fd-4e98-8c8a-daa7d8f872b0","FDA Menveo",{"kind":188,"url":189,"label":124},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=J07AH08",{"kind":191,"url":172,"label":192},"darooyab","Meningococcal-Vaccines",{"pregnancy":194,"lactation":203,"pediatric":211,"geriatric":218},{"level":195,"text":196,"quote":199,"refs":200},"caution",{"fa":197,"en":198},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Risk Summary All pregnancies have a risk of birth defect, loss, or other adverse outcomes.",[201],{"source":35,"section":202},"8.1",{"level":195,"text":204,"quote":207,"refs":208},{"fa":205,"en":206},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","Data are not available to assess the effects of MENVEO in the breastfed infant or on milk production\u002Fexcretion.",[209],{"source":35,"section":210},"8.2",{"level":195,"text":212,"quote":215,"refs":216},{"fa":213,"en":214},"برچسب برای کودکان شرط، محدودیت سنی یا نکته دارد؛ جمله برچسب در زیر آمده است.","The label has conditions, age limits or notes for children; the label sentence is quoted below.","Safety and effectiveness of MENVEO in children aged younger than 2 months have not been established.",[217],{"source":35,"section":90},{"level":195,"text":219,"quote":222,"refs":223},{"fa":220,"en":221},"برچسب: در سالمندان با احتیاط و معمولاً از دوز پایین شروع شود.","Label: use with caution in older adults, usually starting at the low end of the dose range.","Safety and effectiveness of MENVEO in adults aged 65 years and older have not been established.",[224],{"source":35,"section":225},"8.5",1792156186135]